facebook
Eczacıbaşı Pharmaceutical and Industrial Investment Co.

FAQ

Could you briefly give information about EİS Eczacıbaşı İlaç, Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. (EİS)?
Dr. Nejat F. Eczacıbaşı completed his studies in 1942, returned home, and established the foundation of Turkey's first modern pharmaceutical production facility, Eczacıbaşı Pharmaceutical Industry in 1952. The company lead Turkish pharmaceutical industry with its high standards and innovations.
 
To benefit from the changes in Turkey, Eczacıbaşı Pharmaceutical Industry started to seek strategic partners within the global pharmaceutical market, in 2007, it transferred 75 per cent of their shares in Eczacıbaşı Sağlık Ürünleri and Eczacıbaşı Özgün Kimya to Zentiva N.V., one of Europe's leading companies in the field of equivalent pharmacy field. The transfer of the remaining 25 percent partnership took place in July 2009.
 
The title of Eczacıbaşı Pharmaceutical Industry has changed and the new title ''Eczacıbaşı Pharmaceutical and Industrial Investment Co'' was published in Turkish Trade Registry Gazette on 24 November 2008, No. 7195 edition. Eczacıbaşı İlaç, Sınai ve Finansal Yatırımlar, which does not have production activities, has a kind of holding structure with its existing subsidiaries, business partnerships and affiliates. Within this structure, it directly engages in real estate development activities and acts as a strategic partner in healthcare, building products and other industries.
 
When was EIS established?
EIS was established on October 24th, 1951.
 
What is the share code of EIS on BIST?
ECILC

When did EIS go public?
EIS went public in 1990.
 
On which stock exchange is EIS traded?
The shares of EİS are traded on Borsa İstanbul A.Ş.
 
What is the free float rate of EIS?
According to Central Registry Agency Inc. records; as of 30 September 2021, it is accepted that the shares representing 19.46% of the company's capital are "in circulation".
 
What is the core activity of EIS?
It has a kind of holding structure with its existing subsidiaries, business partnerships and affiliates. Within this structure, it directly engages in real estate development activities; it plays a role as a partner in health, building products and other industries.
 
Could you give information about affiliate and investments of EIS?
 
Trade TitleShare Ratio (%)
EİP Eczacıbaşı İlaç Pazarlama A.Ş.99.92
Eczacıbaşı Gayrimenkul Geliştirme ve Yatırım A.Ş.99.49
Eczacıbaşı İlaç Ticaret A.Ş.94.70
Eczacıbaşı Monrol Nükleer Ürünler Sanayi ve Ticaret A.Ş.78.00
Tasfiye Halinde Eczacıbaşı-Baxter Hastane Ürünleri San. ve Tic. A.Ş.50.00
Eczacıbaşı Holding A.Ş.37.28
Ekom Eczacıbaşı Dış Ticaret A.Ş.26.36
Vitra Karo Sanayi ve Ticaret A.Ş.25.00
Eczacıbaşı Bilişim Sanayi ve Ticaret A.Ş.11.21
 
Sector/Market of ActivityCorporate Name
Healthcare Sector 
Reference and generic pharmaceuticals marketEİP Eczacıbaşı İlaç Pazarlama A.Ş.
 Eczacıbaşı İlaç Ticaret A.Ş.
Hospital products marketTasfiye Halinde Eczacıbaşı-Baxter Hastane Ürünleri San. ve Tic. A.Ş.
Nuclear medicine sectorEczacıbaşı Monrol Nükleer Ürünler Sanayi ve Ticaret A.Ş.
 Monrol Europe SRL
 Monrol Egypt for Manufacturing LLC
 Radiopharma Egypt (S.A.E))
 Monrol Bulgaria LTD
 Eczacıbaşı Monrol Nuclear Products Industry & Trade Co - Jordan
 Monrol MENA LTD
 Monrol Gulf DMCC
 HSM Consulting LTD
Real Estate Activities 
Kanyon(*)
Ormanada Project(**)
Real estate developmentEczacıbaşı Gayrimenkul Geliştirme ve Yatırım A.Ş.
Other 
Ceramic coating marketVitra Karo Sanayi ve Ticaret A.Ş.
Exportation servicesEkom Eczacıbaşı Dış Ticaret A.Ş.
 
(*)   This means the entire Kanyon Office Block and the half of the Shopping Mall.
(**) On December 31st, 2007, Eczacıbaşı İlaç, Sınai ve Finansal Yatırımlar purchased the half of 22 building plots equal to 196,409.74 m2 in total which were situated in Yorgancı Çiftliği Location, Uskumru Quarter of Sarıyer District. And the other half of them belongs to Eczacıbaşı Holding A.Ş. In Ormanada, there are 273 residences as 188 villas and 85 row houses; and there are 150 residences on the 1st Phase and 123 residences on the 2nd Phase. The delivery of the residences on the first phase started as of April 2013 and the delivery of the residences on the second phase started as of December 2013.
 
Information on the activities of subsidiaries, affiliates and business partnerships are included in the annual reports that are prepared quarterly and annually. Click here to reach the annual reports of EIS.
 
How can I reach the articles of association of EIS?
Click here to reach the articles of association of EIS.
 
How is shareholding structure EİS?
Click here for shareholding structure of EIS.
 
How much is ıssued capital of EİS?
EIS’ issued capital is TL 685,260,000.
 
Could you give information about the capital movements of EIS over the years?
Click here for information about the capital movements of EIS.
 
What is the number of shares representing the issued capital of EIS? Do the shares have any privileges?
The number of shares representing the issued capital of EIS is 68,526,000.000. There is no privileged share and each share has one voting right.
 
How many people does the board of directors of EIS consist of? What is the number of independent members in the board of directors?
The Board of Directors of the company consists of 6 members and 2 of the members are independent members. Click here to reach information about the board of directors.
 
What period does the fiscal year of EIS cover?
The fiscal year of EIS starts on January 1 and ends on December 31.
 
When does EİS announce its financial results?
EİS discloses its consolidated financial results quarterly. Click here to reach the quarterly financial reports.
 
When does the ordinary general assembly of EIS convene?
The Ordinary General Assembly Meeting of EIS for 2020 was held on Tuesday, April 13, 2021. Click here for information on the 2020 Ordinary General Assembly Meeting.
 
What is the profit distribution policy of EIS?
Click here to reach the profit distribution policy of EIS.
 
What is the amount and rates of share of profit by EIS in the last 5 years?
Click here to reach the profit distribution details of EIS.
 
Who is the independent audit company of EIS?
At the Ordinary General Assembly Meeting of EIS dated 13.04.2021, it has been resolved that, in compliance with Turkish Commercial Code, Capital Markets Law and the Decree in the force of Law numbered 660 and principles determined pursuant to the secondary legislation that is effective in this scope, PwC Bağımsız Denetim ve Serbest Muhasebeci Mali Müşavirlik Anonim Şirketi (PricewaterhouseCoopers) be appointed as the independent audit institution with a view to subjecting financial reports of our company in the fiscal period of  01 January 2021 - 31 December 2021 to independent auditing and performing other relevant operations.
 
How can I access the annual reports of EIS?
Click here to reach the annual reports of EIS.
 
How can I reach Rules of Conduct of EIS?
Click here to see Rules of Conduct of EIS.
 
Who can EIS investors contact regarding their questions?
Click here for contact information of EİS Investor Relations Department.
 
How can I get more information Eczacıbaşı Group?
Click here to learn about more about Eczacıbaşı group.